CD47 and neoplasm: In 191 resected NSCLC specimens, CD47 was more frequently overexpressed in females, never-smokers, and lung adenocarcinoma patients, significantly correlating with EGFR mutations but inversely with PD-L1 levels and tumor mutation burden (111).